-+ 0.00%
-+ 0.00%
-+ 0.00%

Aquestive Therapeutics faces securities lawsuit; shares fell from $6.21 to $3.91 on FDA-cited Anaphylm NDA deficiencies

Reuters·03/26/2026 13:03:10

Please log in to view news